Market Tracker

02/05 5:16pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

142.28
Delayed Data
As of Feb 05
 -3.74 / -2.56%
Today’s Change
130.51
Today|||52-Week Range
208.88
-25.41%
Year-to-Date

Today’s Trading

Previous close146.02
Today’s open146.20
Day’s range139.13 - 146.90
Volume2,132,320
Average volume (3 months)1,679,211
Market cap$32.1B
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)-4.62%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+46.49%
P/E ratio128.9
Price/Sales16.84
Price/Book8.58

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-0.35-0.36%
SHPGShire-6.02-3.69%
MYLMylan NV-0.92-1.76%
VRTXVertex Pharmaceutica...-5.11-5.57%
Data as of 4:01pm ET, 02/05/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$1.14
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
Cheshire, Connecticut

Forecasts